Clinical Trials Logo

Clinical Trial Summary

Elderly patients show different pharmacokinetic and pharmacodynamic variables and usually need smaller doses of anesthetic drugs than younger patients. The purpose of this study was to investigate the optimal effect-site concentration of remifentanil for preventing injection pain during propofol induction in elderly patients by the Dixon's up-and-down method.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03330782
Study type Interventional
Source Ajou University School of Medicine
Contact
Status Completed
Phase Phase 4
Start date November 16, 2017
Completion date June 15, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06020391 - Cooperation for Better Treatment of Polypharmacy in the Community N/A
Completed NCT02490345 - Gabapentin as Adjunctive Treatment for Postoperative Pain Control Phase 1
Completed NCT01931683 - Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA) Phase 4
Withdrawn NCT03938077 - A Community-University Approach to Preventing HIV N/A
Completed NCT02973724 - EC95 of Remifentanil for Preventing Cough N/A
Completed NCT01152970 - F.Y.I.: Flint Youth Injury Study N/A
Completed NCT01489683 - Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine N/A
Completed NCT03368456 - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention N/A
Completed NCT02379455 - Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study N/A
Completed NCT01852539 - Dexmedetomidine for Laryngeal Mask Airway Insertion Phase 4
Completed NCT01963130 - Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study N/A
Recruiting NCT01496105 - Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion Phase 4
Completed NCT02334046 - Remifentanil for Smooth Emergence in Elderly Patients Phase 4
Completed NCT00876941 - Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use Phase 3